5-amino-1mq clinical trial human 5-AMINO 1MQ - 10mg Vial
Description
Studies treating mild to moderate B12 deficiency in older people have failed to provide cognitive benefits: A clinical trial from the Netherlands measured the cognitive response to B12 supplements in people 70 years old with mild B12 deficiency and MMA levels 320 nmol/l (average: ~450 nmol/l)
Q: What are some key biomarkers to monitor when determining 5-Amino-1MQ dosage efficacy
The criteria below reflect the standards clinics commonly use during an initial evaluation, though a full medical assessment always determines the final answer
its about mindset, too
Dont drink alcohol or strong teas the first few days
